| The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer N Van Es, VF Franke, S Middeldorp, JW Wilmink, HR Büller Thrombosis research 150, 30-32, 2017 | 87 | 2017 |
| High response rates for T‐VEC in early metastatic melanoma (stage IIIB/C‐IVM1a) V Franke, DMS Berger, WMC Klop, B van der Hiel, BA van de Wiel, ... International journal of cancer 145 (4), 974-978, 2019 | 79 | 2019 |
| Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma B Schermers, V Franke, EA Rozeman, BA Van De Wiel, A Bruining, ... Journal of British Surgery 106 (5), 519-522, 2019 | 37 | 2019 |
| Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes D Verver, D van Klaveren, V Franke, ACJ van Akkooi, P Rutkowski, ... Journal of British Surgery 106 (3), 217-225, 2019 | 37 | 2019 |
| Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria MF Madu, V Franke, MM Bruin, DMS Berger, C Bierman, K Jóźwiak, ... European Journal of Cancer 87, 212-215, 2017 | 27 | 2017 |
| The extent of surgery for stage III melanoma: how much is appropriate? V Franke, ACJ van Akkooi The Lancet Oncology 20 (3), e167-e174, 2019 | 26 | 2019 |
| External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment? MF Madu, V Franke, BA Van de Wiel, W Klop, K Jóźwiak, WJ van Houdt, ... Melanoma research 30 (2), 185-192, 2020 | 22 | 2020 |
| Validation of a nomogram for non-sentinel node positivity in melanoma patients, and its clinical implications: a Brazilian–Dutch study E Bertolli, V Franke, VF Calsavara, MP de Macedo, CAL Pinto, ... Annals of surgical oncology 26 (2), 395-405, 2019 | 21 | 2019 |
| T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model EHA Stahlie, V Franke, CL Zuur, WMC Klop, B van der Hiel, ... Cancer Immunology, Immunotherapy, 1-10, 2021 | 20 | 2021 |
| A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB–IVM1a Melanoma in Four European Countries ACJ van Akkooi, S Haferkamp, S Papa, V Franke, A Pinter, C Weishaupt, ... Advances in therapy 38 (2), 1245-1262, 2021 | 16 | 2021 |
| External validation of the 8th Edition Melanoma Staging System of the American Joint Committee on Cancer (AJCC): Effect of adding EORTC sentinel node (SN) tumor burden criteria … MF Madu, V Franke, B Van De Wiel, WMC Klop, K Józwiak, ... Journal of Clinical Oncology 36 (15_suppl), 9500-9500, 2018 | 10 | 2018 |
| Challenges in sentinel node pathology in the era of adjuvant treatment V Franke, MF Madu, C Bierman, WMC Klop, WJ van Houdt, ... Journal of Surgical Oncology 122 (5), 964-972, 2020 | 6 | 2020 |
| Exogenous Cushing's syndrome due to a Chinese herbalist’s prescription of ointment containing dexamethasone V Franke, WF Scholtens, IA von Rosenstiel, MJ Walenkamp BMJ case reports 2017, bcr-2016-218721, 2017 | 6 | 2017 |
| Complete response to talimogene laherparepvec in a primary acral lentiginous melanoma V Franke, PMG Smeets, JE van der Wal, ACJ van Akkooi Melanoma Research 30 (6), 548-551, 2020 | 5 | 2020 |
| Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma V Franke, B van der Hiel, BA van de Wiel, WMC Klop, S ter Meulen, ... European Journal of Cancer 90, 149-152, 2018 | 5 | 2018 |
| Talimogene laherparepvec monotherapy, an elegant alternative to systemic immunotherapy for the treatment of early metastatic melanoma V Franke British Journal of Dermatology 181 (1), 20-21, 2019 | 2 | 2019 |
| Challenges in sentinel node (SN) pathology in the era of adjuvant treatment: The risk of over and undertreatment stress the need for expert pathology review. V Franke, MF Madu, C Bierman, WMC Klop, WJ van Houdt, ... Journal of Clinical Oncology 37 (15_suppl), 9593-9593, 2019 | 1 | 2019 |
| 1112P Intralesional therapy with talimogene laherparepvec for stage IIIB-IVM1a melanoma is able to achieve a high rate of complete and durable responses and is associated with … E Stahlie, V Franke, L Zuur, M Klop, BA van de Wiel, B van der Hiel, ... Annals of Oncology 31, S750, 2020 | | 2020 |
| Rate of complete and durable responses of intralesional therapy with talimogene laherparepvec for stage IIIB-IVM1a melanoma and association with tumor load. EHA Stahlie, V Franke, CL Zuur, WMC Klop, B Van Der Hiel, ... Journal of Clinical Oncology 38 (15_suppl), e22089-e22089, 2020 | | 2020 |
| Re-introduction of T-VEC monotherapy in recurrent stage IIIB/C-IVM1a melanoma is effective V Franke, EHA Stahlie, B van der Hiel, BA van de Wiel, M Wouters, ... Annals of Oncology 30, v547, 2019 | | 2019 |
